These medtech companies raised the most VC last year

Perhaps there’s a ray of hope that venture capital funding is recovering a bit for the medical device industry. VC firms invested more than $2.8 billion in 2017, an increase of more than $647 million from 2016, according to the MoneyTree Report from PricewaterhouseCoopers (PwC) and CB Insights. There were a total 229 deals involving

Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Secant Group officials think they’ve cracked vascular regeneration: Here’s how

Secant Group today announced what it described as game-changing technology to advance vascular regeneration, solving problems that surgeons presently have when it comes to vascular harvesting and the non-resorbable synthetic graft compliance mismatching. The technology, which Secant (Telford, Pa.) developed in partnership with its sister company SanaVita Medical, involves a synthetic small bore vessel with a hollow

Abbott, Nevro tout spinal cord stimulation tech

Abbott (NYSE:ABT) and Nevro (NYSE:NVRO) touted their spinal cord stimulation technologies at the annual North American Neurological Society meeting in Las Vegas. Two-year data from Abbott’s 42-patient Sunburst study revealed that a majority of patients chose its BurstDR therapy when given the choice during the long-term follow-up period and that stimulation from BurstDR provided pain relief […]

How medtech could stop the drug overdose crisis in the U.S.

The opioid epidemic is one of the deadliest problems facing the U.S. today. Through the development of new pain management devices, medtech could be a leader in solving the crisis. The prescription opioid overdose crisis in America didn’t start until the late 1990s, when pharmaceutical companies touted prescription painkillers that weren’t supposed to be addictive.

Teleflex Medical launches new suture technology to reduce tissue strangulation

Teleflex Medical has created a new suture technology that may reduce tissue strangulation and a cutting effect in situations where tissue pull-through is a risk. The technology, called Force Fiber Fusion, is a two-in-one construct that goes from a round suture to a flat braid center segment and back to round suture. It is made

Abbott nabs CMS reimbursement for FreeStyle Libre continuous glucose monitor

Abbott (NYSE:ABT) said today that its FreeStyle Libre continuous glucose monitor is now available to Medicare patients, after the Centers for Medicare & Medicaid Services determined that the device can be classified as a therapeutic CGM. The FreeStyle Libre is designed to read glucose levels through a sensor worn on the back of a person’s upper […]

Zimmer Biomet wins FDA nod for Sidus stem-free shoulder system

Zimmer Biomet (NYSE:ZBH) said today it won FDA clearance for its Sidus stem-free shoulder system. The newly cleared Sidus system is designed as a total shoulder arthroplasty solution for patients with good bone stock with either osteoarthritis, post-traumatic arthrosis, focal avascular necrosis of the humeral head or those who’ve had previous surgeries of the shoulder that […]

Medtech stories we missed this week: Dec. 29, 2017

From NanoVibronix’s new Indian regulatory and distribution agreement to Guided Therapeutics’s Turkish distribution deal, here are five medtech stories we missed this week but thought were still worth mentioning. 1. NanoVibronix inks deal with Indian regulatory and distribution consultant NanoVibronix announced in a Dec. 20 press release that it has signed Morulaa HealthTech as its regulatory

FDA clears device that treats diabetic foot ulcers for market

The FDA announced today that it has cleared the Dermapace System diabetic foot ulcer treatment device for market. Dermapace System is the first shockwave device to treat foot ulcers caused by diabetes, according to the device’s creator Sanuwave. “Diabetes is the leading cause of lower limb amputations,” Binita Ashar, director of the division of surgical

AdvaMed asks Trump to overturn medical device tax

AdvaMed CEO Scott Whitaker has penned a letter to President Donald Trump, urging the president to work with Congress to overturn the medical device tax. Whitaker in his letter today congratulated Trump on today’s passage of the Republican-backed tax plan, while noting that Congress has failed to suspend the 2.3% levy imposed on U.S. medical

Medtech stories we missed this week: Dec. 8, 2017

From Minimus Spine’s European distribution deal to Stimwave receiving FDA clearance, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Minimus Spine inks EU distribution deal Minimus Spine announced in a Dec. 4 press releasethat it has signed its first European distribution deal with Italian company Moss and

These 10 medtech companies care a lot about research

Among the world’s largest medtech companies, these 10 spent the largest portion of their budgets on research and development. So what have they produced? Every year, Medical Design & Outsourcing pulls financial regulatory filings and reaches out to major, companies in some cases to create a list of the 100 largest medical device companies in

Pages: 1 2 3 4 5 6 7 8 9 10 11

Philips is expanding its radiology offerings: Here’s how

Philips today announced three new products and services related to its radiology offerings, including 3D printed models, a new CT scanner and an extension of a partnership with Banner Health. On the 3D printing front, agreements with industry leaders 3D Systems and Stratasys will enable Philips customers through Philips’s IntelliSpace Portal 10 to have a seamless

This manufacturing method can create flexible wearable electronics

Wearable electronics are useful in measuring vitals and activity, but usually aren’t fit to flex with the body. Harvard researchers have come up with a flexible solution using 3D printing. The human skin flexes and stretches to match how our bodies move. Anything worn tight on the skin needs to be made of a flexible

Artificial organ market worth expected to double in the next 5 years

The artificial organ market is expected to more than double by 2022, according to a market analysis report from Yole Développement in France. The market is expected to be work $1.3B in 2017 and with a consumer annual growth rate (CAGR) of 20%, it is expected to be work $3.5B by 2022. “This impressive growth